Plans to ban indirect private equity ownership of MVZ outpatient facilities in Germany would have a huge impact on radiotherapy according to an operator source and panellist at HBI 2023.
GenesisCare, the radiotherapy group with operations in the US, UK, Australia and Spain, has filed for voluntary reorganisation under chapter 11 of the US bankruptcy code and will look to sell off its US assets. HBI speaks to an advisory source to find out more.
The AI revolution is coming for oncology, according to CEO Ralph Hefti who helms pan-European radiotherapy group Stingray Healthcare. We catch up with the HBI 2023 panelist to find out more.
The long awaited consolidation of French imaging is set to ramp up, especially in the attractive fields of radiology and teleradiology, according to French sources.
Last month, thought leaders from private healthcare systems across the globe gathered in Cape Town, South Africa, to network, share their findings, and consider how emerging markets can become more resilient. HBI was there, and these are our key themes and takeaways.
In April last year, medical device giant Siemens Healthineers acquired Varian Medical Systems in one of the largest all cash MedTech transactions in history. HBI catches up with Varian CEO Chris Toth to find out more about the deal, and Varian’s plans for the future.
Giuseppe Recchi is stepping down as CEO of Affidea, Europe’s largest imaging company. The new CEO will continue the company’s ambition to expand into more European markets.
There are huge opportunities in imaging and radiotherapy according to a panel at HBI 2022, given how much demand will grow and how many unconsolidated markets there are. But panellists had differing views on the best business model to capitalise on this.
A breakfast briefing session at HBI 2022 by Affidea, the largest pan-European provider of advanced diagnostics, outpatient and cancer care, took a deep dive into driving operational efficiencies and improving patient experience.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.OkCookies Policy
